1
LI YUN LONG: Substituted fused aryl and heteroaryl derivatives as pi3k inhibitors. INCYTE CORPORATION, Goddard Christine A, June 23, 2011: WO/2011/075630 (22 worldwide citation)

The present invention provides fused aryl and heteroaryl derivatives of Formula I that modulate the activity of phosphoinositide 3-kinases (PI3Ks) and are useful in the treatment of diseases related to the activity of PI3Ks including, for example, inflammatory disorders, immune-based disorders, canc ...


2
Yun Long Li, Andrew P Combs, Eddy W Yue, Hui Yin Li: Substituted fused aryl and heteroaryl derivatives as PI3K inhibitors. Incyte Corporation, Fish & Richardson P C, March 25, 2014: US08680108 (14 worldwide citation)

The present invention provides fused aryl and heteroaryl derivatives of Formula I: wherein X, V, Y, U, W, Z, R1, R2, Cy, and Ar are defined herein, that modulate the activity of phosphoinositide 3-kinases (PI3Ks) and are useful in the treatment of diseases related to the activity of PI3Ks including, ...


3
Yun Long Li, Andrew P Combs, Eddy W Yue, Hui Yin Li: Substituted fused aryl and heteroaryl derivatives as pi3k inhibitors. July 28, 2011: US20110183985-A1

The present invention provides fused aryl and heteroaryl derivatives of Formula I: wherein X, V, Y, U, W, Z, R1, R2, Cy, and Ar are defined herein, that modulate the activity of phosphoinositide 3-kinases (PI3Ks) and are useful in the treatment of diseases related to the activity of PI3Ks including, ...